Understanding a decade of safety reporting for sacral neuromodulation in the Food and Drug Administration Manufacturer and User Facility Device Experience database.
PMID: 37497812 ·
C, a, i, t, l, i, n, , E, , C, a, r, l, t, o, n, ;, , C, o, l, b, y, , P, , S, o, u, d, e, r, s, ;, , N, a, t, h, a, n, , A, , C, h, e, r, t, a, c, k, ;, , R, a, m, y, , S, , G, o, u, e, l, i, ;, , G, a, r, y, , E, , L, e, m, a, c, k, ;, , J, e, n, n, i, f, e, r, , T, , A, n, g, e, r, ;, , L, y, n, n, , M, c, C, l, e, l, l, a, n, d, ;, , M, a, u, d, e, , E, , C, a, r, m, e, l
광고
초록
Over 350 000 sacral neuromodulation (SNM) devices have been implanted since approval by the Food and Drug Administration (FDA) in 1998. SNM technology and clinical applications have evolved, with minimal safety updates after initial trials. We aim to provide an updated overview of real-world SNM safety. These insights will guide informed consent, preoperative counseling, and patient expectation-setting. The FDA Manufacturer and User Facility Device Experience (MAUDE) database is a repository for
광고
공식 출처
PubMed에서 보기 →데이터는 PubMed / NCBI에서 제공됩니다. 전문과 최신 정보는 반드시 공식 기록을 확인하세요.